Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC

Listen to Egbert F. Smit, MD, PhD; David Planchard, MD, PhD; and Helena A. Yu, MD, answer audience questions from a live CCO webinar regarding clinical data on antibody–drug conjugates in NSCLC, including biomarker testing, patient selection, and toxicity management.